Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05134922
Title Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
Recruitment Available
Gender female
Phase Expanded access
Variant Requirements No
Sponsors Celcuity, Inc.
Indications

Her2-receptor negative breast cancer

Therapies

Gedatolisib

Age Groups: adult
Covered Countries USA


No variant requirements are available.